BNTC - Benitec Biopharma Ltd Stock Price, Fair Value and News

$12.50+0.85 (+7.30%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

BNTC Price Action

Last 7 days

-4.0%

Last 30 days

-21.2%

Last 90 days

-10.7%

Trailing 12 Months

25%

BNTC RSI Chart

BNTC Valuation

Market Cap

423.3M

Price/Earnings (Trailing)

-12.26

Price/Sales (Trailing)

5.9K

Price/Free Cashflow

-18.92

BNTC Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

BNTC Fundamentals

BNTC Revenue

Revenue (TTM)

75.0K

BNTC Earnings

Earnings (TTM)

-34.5M

Earnings Growth (Yr)

-77.9%

Earnings Growth (Qtr)

-2.21%

BNTC Profitability

Return on Equity

-36.88%

Return on Assets

-35.94%

Free Cashflow Yield

-5.28%

BNTC Investor Care

Shares Dilution (1Y)

45.85%

Diluted EPS (TTM)

-1

BNTC Alerts

1 major insider buys recently.

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	0	0	0	0
2024	0	0	0	0
2023	116.0K	75.0K	0	0
2022	82.0K	74.0K	0	87.0K
2021	1.8M	123.0K	0	102.5K
2020	8.7M	7.0M	5.3M	3.6M
2019	0	12.2M	10.5M	0

Get all data in R, Python etc through our Historical Stock Data APIs

About Benitec Biopharma Ltd

Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. The company was incorporated in 1995 and is headquartered in Hayward, California.

CEO	Dr. Jerel A. Banks M.D., Ph.D.
WEBSITE	https://benitec.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	18

Benitec Biopharma Ltd Frequently Asked Questions

What is the ticker symbol for Benitec Biopharma Ltd? What does BNTC stand for in stocks?

BNTC is the stock ticker symbol of Benitec Biopharma Ltd. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Benitec Biopharma Ltd (BNTC)?

As of Wed Dec 03 2025, market cap of Benitec Biopharma Ltd is 423.28 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BNTC stock?

You can check BNTC's fair value in chart for subscribers.

Is Benitec Biopharma Ltd a good stock to buy?

The fair value guage provides a quick view whether BNTC is over valued or under valued. Whether Benitec Biopharma Ltd is cheap or expensive depends on the assumptions which impact Benitec Biopharma Ltd's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BNTC.

What is Benitec Biopharma Ltd's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, BNTC's PE ratio (Price to Earnings) is -12.26 and Price to Sales (PS) ratio is 5.94 Thousand. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BNTC PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Benitec Biopharma Ltd's stock?

In the past 10 years, Benitec Biopharma Ltd has provided -0.362 (multiply by 100 for percentage) rate of return.